Ackman: Lawyers have documents purported to show Allergan misled on Valeant: Reuters
Billionaire investor William Ackman has turned up the heat on Allergan Inc, accusing the U.S. Botox maker’s board of misleading investors to fend off a hostile takeover bid from Canada's Valeant Pharmaceuticals, Reuters reported. Ackman's hedge fund Pershing Square Capital Management is Allergan’s biggest shareholder. Ackman has been working with Valeant for months to push the Botox maker into selling itself to Valeant. Allergan has steadfastly refused, calling Valeant’s offer too low.
17 October 2014•3 mins read
